Last Update 22 May 26
Fair value Decreased 23%BEI: Brand Execution And Buyback Program Will Shape Future Performance Resilience
Beiersdorf's analyst price target has been reduced from about €115 to roughly €88. This reflects analysts' updated expectations for slower revenue growth, slightly lower margins and a lower future P/E, alongside a series of recent target cuts and rating downgrades, particularly around concerns for Nivea's market share and competitive pressure.
Analyst Commentary
Recent research has become more mixed, with several target cuts and rating changes clustering over a short period. This has created a split between bullish analysts who still see support for the investment case and bearish analysts who are more focused on execution risk and market share pressure, especially around Nivea.
Bullish Takeaways
- Some analysts keep higher targets in the triple digit € range, which signals that they still see room for value creation if Beiersdorf executes on its plan and defends key brands.
- One firm maintains an Overweight stance with a €105 target, indicating confidence that current concerns about the stock are already reflected in the valuation and that long term growth drivers could still support a higher multiple.
- Another large broker upgraded the stock, which adds support to the view that recent weakness and target cuts do not fully undermine the long term equity story.
- Where models have been updated after the latest fiscal year results, some analysts have kept neutral ratings, suggesting they see the current share price as roughly in line with their fundamental assessment rather than clearly overvalued.
Bearish Takeaways
- Several bearish analysts have cut targets sharply, in some cases from €100 to €70, reflecting reduced confidence in Beiersdorf's ability to sustain its previous growth assumptions and margin expectations.
- Multiple downgrades to Hold, Underperform or Underweight point to rising concern that Nivea's market share losses, complicated price positioning and intense competition could weigh on execution and earnings delivery.
- Comments that there are "no quick fixes" for Nivea's share pressure suggest that any turnaround in core brands may take time, which can cap the P/E that investors are willing to pay in the near term.
- Some bearish analysts explicitly describe the recent share price de-rating as a sign of a lower growth trajectory rather than an attractive entry point, which frames current valuation as fair or even demanding relative to their revised expectations.
What's in the News
- Beiersdorf announced a share repurchase program of up to €750 million, with the plan valid for two years. (Key Developments)
- The Board of Directors authorized a buyback plan on March 2, 2026, supporting the previously announced repurchase framework. (Key Developments)
- For 2026, Beiersdorf provided guidance for flat to slightly growing organic sales and an operating EBIT margin, excluding special factors, slightly below the prior year's 14.0% level, compared with 2.4% organic sales growth and a 14.0% margin reported for 2025. (Key Developments)
Valuation Changes
- Fair Value: cut from €115.15 to €88.37, a reduction of about 23%, reflecting more cautious assumptions in the model.
- Discount Rate: risen slightly from 5.39% to 5.41%, implying a slightly higher required return applied to future cash flows.
- Revenue Growth: trimmed from 3.14% to 2.02%, indicating more conservative expectations for future euro revenue expansion.
- Net Profit Margin: eased from 10.59% to 9.75%, pointing to lower projected profitability on each euro of sales.
- Future P/E: lowered from 26.0x to 21.3x, suggesting a reduced valuation multiple applied to the company’s projected earnings.
Key Takeaways
- Science-driven product innovation and premiumization are boosting brand equity and enabling profitable growth in both premium and mass-market skincare segments.
- Expansion in emerging markets and advances in digital transformation are increasing market reach and supporting sustainable revenue and margin improvements.
- Increased competition, market uncertainty, retailer pressures, and rising costs are constraining Beiersdorf's growth, pricing power, and profitability across core and premium segments.
Catalysts
About Beiersdorf- Manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia.
- Breakthrough innovation in science-based skincare, particularly the global rollout of the Epicelline anti-aging ingredient under both Eucerin and NIVEA, positions Beiersdorf to capture increased demand from an aging, health-conscious population, driving higher-margin revenue growth from both premium and mass-market channels.
- Strategic expansion in emerging markets-illustrated by Eucerin's successful entry and strong growth in China and India-capitalizes on rising middle class purchasing power and urbanization, expanding Beiersdorf's addressable market and providing a runway for sustained organic revenue growth.
- Aggressive pivot towards premiumization and premium science-backed offerings (e.g., NIVEA Epigenetics Serum, Derma Control deodorant, Thiamidol range) enables higher average selling prices, improved consumer repurchase rates, and supports gross margin expansion over the long term.
- Accelerating digital transformation in marketing, distribution, and direct-to-consumer approaches, especially in China and across e-commerce, is enhancing brand equity, increasing ROI on marketing spend, and supporting both top-line growth and operating leverage.
- Recent resolution of retailer delistings and pricing negotiations in Europe, combined with a robust innovation/launch pipeline in H2 and broader geographic relistings, is expected to yield a rebound in sales volumes and positively impact near-term revenue and profit margins.
Beiersdorf Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Beiersdorf's revenue will grow by 2.0% annually over the next 3 years.
- Analysts assume that profit margins will increase from 9.5% today to 9.8% in 3 years time.
- Analysts expect earnings to reach €1.0 billion (and earnings per share of €4.88) by about May 2029, up from €939.0 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €1.1 billion in earnings, and the most bearish expecting €898.3 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 21.3x on those 2029 earnings, up from 16.9x today. This future PE is greater than the current PE for the GB Personal Products industry at 16.9x.
- Analysts expect the number of shares outstanding to decline by 1.29% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 5.41%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Intensifying competition from local brands and private labels, particularly in emerging markets and mass market segments, is eroding NIVEA's volume growth and market share, which could lead to lower revenues and compressed pricing power over the long term.
- Weaker-than-anticipated market growth in key regions (notably emerging markets and Eastern Europe), combined with volatile demand and consumer caution, is slowing Beiersdorf's top-line organic growth and undermining long-term revenue expansion.
- Persistent retailer pressure in Europe-evidenced by delistings, heightened demands for price reductions, and delayed relistings-suggests that Beiersdorf's pricing strategies may negatively affect shelf presence and sales volumes, risking downward pressure on revenue and net margins if retailer relations do not stabilize.
- Ongoing underperformance in the luxury La Prairie segment and slow progress in building scale for premium brands in the US and travel retail reduce anticipated margin expansion and leave Beiersdorf vulnerable to market headwinds in high-margin categories, dragging on overall group profitability.
- Rising costs due to innovation-driven marketing investments, the need to overinvest in digitalization and e-commerce, ongoing regulatory changes (such as US/Swiss tariffs), and unfavorable foreign exchange effects are collectively raising the cost base faster than sales growth, resulting in only modest---or flat---net earnings and jeopardizing margin improvement in the medium to long term.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €88.37 for Beiersdorf based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €110.0, and the most bearish reporting a price target of just €68.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €10.5 billion, earnings will come to €1.0 billion, and it would be trading on a PE ratio of 21.3x, assuming you use a discount rate of 5.4%.
- Given the current share price of €72.54, the analyst price target of €88.37 is 17.9% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Beiersdorf?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.